Advertisement

Topics

[Comment] Addressing antimicrobial resistance in the UK and Europe

19:04 EST 10 Nov 2017 | The Lancet

Antimicrobial resistance (AMR) has received substantial attention in recent years. Since bacteria evolve to resist the effects of existing antibiotics, infections can become more difficult to treat and subsequently modern medical interventions can become more dangerous for patients. Fear of so-called superbugs has spurred international authorities into action. In 2011, WHO developed a European strategic action plan on antibiotic resistance,1 which set forth strategic objectives to aid European member states in addressing the complex factors that cause AMR.

Original Article: [Comment] Addressing antimicrobial resistance in the UK and Europe

NEXT ARTICLE

More From BioPortfolio on "[Comment] Addressing antimicrobial resistance in the UK and Europe"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

MRSA (methicillin-resistant Staphylococcus aureus)
MRSA (methicillin-resistant Staphylococcus aureus) is a family of bacteria with resistance to one or more major antibiotics. There are currently 17 different strains of MRSA. Two particular strains, EMRSA15 and EMRSA16  account for 96% of MRSA blood...